A detailed history of Dimensional Fund Advisors LP transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 145,524 shares of LIFE stock, worth $270,674. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,524
Previous 145,524 -0.0%
Holding current value
$270,674
Previous $227,000 18.94%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$0.0 - $2.07 $0 - $106,025
-51,220 Reduced 26.03%
145,524 $227,000
Q1 2024

May 10, 2024

BUY
$1.42 - $2.02 $77,384 - $110,081
54,496 Added 38.31%
196,744 $383,000
Q4 2023

Feb 07, 2024

SELL
$1.11 - $1.51 $104,563 - $142,243
-94,201 Reduced 39.84%
142,248 $200,000
Q3 2023

Nov 09, 2023

SELL
$1.55 - $2.23 $64,100 - $92,221
-41,355 Reduced 14.89%
236,449 $373,000
Q2 2023

Aug 09, 2023

BUY
$1.72 - $2.57 $223,653 - $334,179
130,031 Added 87.99%
277,804 $600,000
Q1 2023

May 12, 2023

SELL
$1.88 - $2.5 $93,847 - $124,797
-49,919 Reduced 25.25%
147,773 $310,000
Q4 2022

Feb 09, 2023

BUY
$2.02 - $2.49 $57,230 - $70,546
28,332 Added 16.73%
197,692 $432,000
Q3 2022

Nov 10, 2022

BUY
$2.79 - $4.15 $60,721 - $90,320
21,764 Added 14.75%
169,360 $508,000
Q2 2022

Aug 12, 2022

SELL
$2.63 - $5.61 $143,829 - $306,799
-54,688 Reduced 27.04%
147,596 $418,000
Q1 2022

May 13, 2022

SELL
$4.75 - $7.54 $116,033 - $184,187
-24,428 Reduced 10.77%
202,284 $1.08 Million
Q4 2021

Feb 09, 2022

BUY
$7.29 - $9.5 $17,736 - $23,113
2,433 Added 1.08%
226,712 $1.69 Million
Q3 2021

Nov 12, 2021

BUY
$4.22 - $12.48 $14,141 - $41,820
3,351 Added 1.52%
224,279 $2.04 Million
Q2 2021

Aug 12, 2021

BUY
$3.62 - $4.88 $566,631 - $763,856
156,528 Added 243.06%
220,928 $1.08 Million
Q1 2021

May 14, 2021

BUY
$3.53 - $8.06 $159,803 - $364,876
45,270 Added 236.64%
64,400 $287,000
Q4 2020

Feb 25, 2021

BUY
$3.07 - $4.66 $58,729 - $89,145
19,130 New
19,130 $74,000

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.